Galapagos, Thermo Fisher to Collaborate on Expanding Manufacturing of Cancer Drug
04 Enero 2024 - 3:44PM
Noticias Dow Jones
By Ben Glickman
Galapagos said it had entered an agreement with Thermo Fisher
Scientific to expand manufacturing of its immune-cell cancer
treatment candidate.
The company said that Thermo Fisher had agreed to provide CAR-T
manufacturing and kitting services for Galapagos' CAR-T
hemato-oncology clinical program in the San Francisco area.
Galapagos in November signed a deal with Landmark Bio to
manufacture CAR-T in the Boston area.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
January 04, 2024 16:29 ET (21:29 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Thermo Fisher Scientific (NYSE:TMO)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Thermo Fisher Scientific (NYSE:TMO)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
